Microglial activation and polarization in type 2 diabetes-related cognitive impairment: A focused review of...

Area of Science:

• Neuroscience
• Immunology
• Endocrinology

Background:

• Microglia are central nervous system immune cells implicated in cognitive impairment.
• Type 2 diabetes (T2D) is increasingly linked to neurological deficits and cognitive decline.
• Understanding microglial roles in T2D is crucial for addressing associated cognitive impairment.

Purpose of the Study:

• To review the mechanisms of microglial activation and polarization in T2D.
• To elucidate the link between microglial dynamics and T2D-related cognitive impairment.
• To provide insights for future therapeutic strategies targeting microglia.

Main Methods:

• Literature review focusing on microglial activation and polarization in T2D.
• Analysis of studies investigating inflammatory responses, neuronal apoptosis, amyloid-β, and Tau pathology.
• Synthesis of current knowledge on microglial involvement in T2D cognitive dysfunction.

Main Results:

• Microglial activation and polarization are key mediators of T2D-related cognitive impairment.
• These processes contribute to neuroinflammation, neuronal apoptosis, and protein aggregation (amyloid-β, Tau).
• Specific pathways linking T2D to altered microglial states and cognitive deficits are identified.

Conclusions:

• Microglial activation and polarization represent critical mechanisms underlying cognitive impairment in T2D.
• Targeting microglial pathways offers potential therapeutic avenues for T2D-related neurological complications.
• Further research is warranted for clinical translation of microglial-based therapies.